SCHEMBL334476

SCHEMBL334476

Nc1ncc2ccccn12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.55
ALDH1A1 P00352 9/20 0.55
MAPT P10636 5/20 0.55
MAPK14 Q16539 3/20 0.55
LIMK1 P53667 2/20 0.55
CHEK1 O14757 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
HSD17B10 Q99714 3/20 0.51
POLB P06746 1/20 0.51
HPGD P15428 5/20 0.50
GLA P06280 1/20 0.50
GAA P10253 1/20 0.50
RAB9A P51151 5/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
NPC1 O15118 3/20 0.49
MAPK1 P28482 2/20 0.49
ABL1 P00519 2/20 0.46
LCK P06239 2/20 0.46
FYN P06241 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2083723 0.83 KDM4E (0.49) KDM4EALDH1A1MAPTMAPK14LIMK1
SCHEMBL23246964 0.78 KDM4E (0.55) KDM4EALDH1A1MAPTMAPK14LIMK1
SCHEMBL398626 0.74 MAP2K2 (0.41) KDM4EALDH1A1MAPTMAPK14LIMK1
SCHEMBL19288598 0.74 KDM4E (0.55) KDM4EALDH1A1MAPTMAPK14LIMK1
SCHEMBL10207538 0.74 KDM4E (0.58) KDM4EALDH1A1MAPTMAPK14LIMK1
SCHEMBL20674503 0.74 KDM4E (0.55) KDM4EALDH1A1MAPTMAPK14LIMK1
SCHEMBL6840370 0.74 ALDH1A1 (0.60) KDM4EALDH1A1MAPTMAPK14LIMK1
SCHEMBL3538954 0.74 KDM4E (0.55) KDM4EALDH1A1MAPTMAPK14LIMK1
SCHEMBL7120114 0.74 KDM4E (0.59) KDM4EALDH1A1MAPTMAPK14LIMK1
SCHEMBL1483347 0.72 KDM4E (0.40) KDM4EALDH1A1MAPTMAPK14LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2903978-B1 GDF-8 INHIBITORS RIGEL PHARMACEUTICALS INC (US) 2022-12-07 EP claimed
US-20250122182-A1 MYST Inhibitors Isosterix, Inc. 2025-04-17 US disclosed
US-20250051343-A1 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES Isosterix, Inc. 2025-02-13 US disclosed
EP-4499609-A1 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES Isosterix, Inc. (US) 2025-02-05 EP disclosed
CN-119301096-A Inhibitors of MYST family lysine acetyltransferase 伊索斯泰里克斯公司 2025-01-10 CN disclosed
US-12187732-B2 Inhibitors of the myst family of lysine acetyl transferases Isosterix, Inc. (US) 2025-01-07 US disclosed
WO-2023192817-A9 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES Isosterix, Inc. (US) 2024-10-03 WO disclosed
CN-118063491-A Imide catalyst auxiliary agent, polyimide film and preparation method 中国科学院化学研究所 2024-05-24 CN disclosed
US-11976075-B2 Inhibitors of the MYST family of lysine acetyl transferases Isosterix, Inc. 2024-05-07 US disclosed
US-20230416260-A1 Inhibitors of the MYST Family of Lysine Acetyl Transferases Isosterix, Inc. 2023-12-28 US disclosed
EP-1985620-A1 10a-AZALIDE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2008-10-29 EP disclosed
WO-2008014888-A2 IMINO-IMIDAZO-PYRIDINE DERIVATIVES HAVING ANTITHROMBOTIC ACTIVITY SANOFI-AVENTIS (FR) 2008-02-07 WO disclosed
WO-2008014888-A2 IMINO-IMIDAZO-PYRIDINE DERIVATIVES HAVING ANTITHROMBOTIC ACTIVITY SANOFI-AVENTIS (FR) 2008-02-07 WO disclosed
US-7306631-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-12-11 US disclosed
EP-1820504-A1 IMINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2007-08-22 EP disclosed
EP-1732509-A1 KERATIN DYEING COMPOSITIONS BICYCLIC 5-6 HETEROAROMATIC DYEING COMPOUNDS WITH ONE RING NITROGEN JUNCTION The Procter and Gamble Company (US) 2006-12-20 EP disclosed
WO-2005097052-A1 KERATIN DYEING COMPOSITIONS BICYCLIC 5-6 HETEROAROMATIC DYEING COMPOUNDS WITH ONE RING NITROGEN JUNCTION THE PROCTER & GAMBLE COMPANY (US) 2005-10-20 WO disclosed
US-20050229333-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-20 US disclosed
EP-0114573-B1 IMIDAZO(1,5-A)PYRIDINE DERIVATIVES CIBA-GEIGY AG (CH) 1988-04-20 EP disclosed
US-4361567-A IMIDAZO(1,5-A)PYRIDINES SCHERING CORPORATION (US) 1982-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051343-A1 INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES KAT6A, KAT6B, KAT2A KDM4E 227/4885ALDH1A1 1618/4885MAPT 1562/4885
US-20230416260-A1 Inhibitors of the MYST Family of Lysine Acetyl Transferases KAT6A, KAT6B, KAT2A KDM4E 227/4885ALDH1A1 1618/4885MAPT 1562/4885
US-12187732-B2 Inhibitors of the myst family of lysine acetyl transferases KAT6A, KAT6B, KAT2A KDM4E 227/4885ALDH1A1 1618/4885MAPT 1562/4885
US-20250122182-A1 MYST Inhibitors MNAT1, SUGT1, ACAT2 KDM4E 844/4885ALDH1A1 3906/4885MAPT 476/4885
US-11976075-B2 Inhibitors of the MYST family of lysine acetyl transferases KAT6A, KAT6B, KAT2A KDM4E 227/4885ALDH1A1 1618/4885MAPT 1562/4885
US-20050229333-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, CKMT1A; CKMT1B, JUP KDM4E 1275/4885ALDH1A1 850/4885MAPT 874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.